EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhanced Risky Choice in Male Rats Elicited by the Acute Pharmacological Stressor Yohimbine Involves Prefrontal Dopamine D1 Receptor Activation

Alexandra Münster, Julia Huster, Susanne Sommer, Corinna Traxler, Angeline Votteler, Wolfgang Hauber iD

International Journal of Neuropsychopharmacology · 2024

DOI: 10.1093/ijnp/pyae006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Neuropsychopharmacology, 2024. Verfasst von Alexandra Münster und 5 weiteren Autor:innen. Beteiligte Einrichtung: Systems Neurobiology Research Unit. Hauptthemen laut MEDLINE: Decision Making, Corticosterone. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acute stress alters risk-based decision-making; however, the underlying neural and neurochemical substrates are underexplored. Given their well-documented stress-inducing effects in humans and laboratory animals, glucocorticoids such as cortisol and corticosterone and the α2-adrenoceptor antagonist yohimbine represent potent pharmacological tools to mimic some characteristics of acute stress.

Methods

Here, we analyzed the effects of the pharmacological stressors corticosterone and yohimbine given systemically on risk-based decision-making in male rats. Moreover, we investigated whether pharmacological stressor effects on risk-based decision-making involve dopamine D1 receptor stimulation in the dorsal prelimbic cortex (PL). We used a risk discounting task that requires choosing between a certain/small reward lever that always delivered 1 pellet and a risky/large reward lever that delivered 4 pellets with a decreasing probability across subsequent trials.

Results

Systemic administration of yohimbine increased the preference for the risky/large reward lever. By contrast, systemic single administration of corticosterone did not significantly promote risky choice. Moreover, co-administration of corticosterone did not enhance the effects of yohimbine on risky choice. The data further show that the increased preference for the risky/large reward lever under systemic yohimbine was lowered by a concurrent pharmacological blockade of dopamine D1 receptors in the PL.

Conclusions

Our rodent data provide causal evidence that stimulation of PL D1 receptors may represent a neurochemical mechanism by which the acute pharmacological stressor yohimbine, and possibly nonpharmacological stressors as well, promote risky choice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Decision MakingCorticosteroneHumansRatsMaleAnimalsYohimbineReceptors, Dopamine D1ProbabilityReward

Stichwörter der Autor:innen

Decision-makingdopamineprelimbic cortexratrisk

Substanzen

YohimbineCorticosteroneReceptors, Dopamine D1

Autor:innen und Institutionen

  • Systems Neurobiology Research Unit.
  • Department of Neurobiology, University of Stuttgart, Stuttgart, Germany.

ORCID-Profile: Wolfgang Hauber

Zitieren

APA

Münster, A., Huster, J., Sommer, S., Traxler, C., Votteler, A., & Hauber, W. (2024). Enhanced Risky Choice in Male Rats Elicited by the Acute Pharmacological Stressor Yohimbine Involves Prefrontal Dopamine D1 Receptor Activation. International Journal of Neuropsychopharmacology. https://doi.org/10.1093/ijnp/pyae006

Vancouver

Münster A, Huster J, Sommer S, Traxler C, Votteler A, Hauber W. Enhanced Risky Choice in Male Rats Elicited by the Acute Pharmacological Stressor Yohimbine Involves Prefrontal Dopamine D1 Receptor Activation. International Journal of Neuropsychopharmacology. 2024. doi:10.1093/ijnp/pyae006

BibTeX
@article{Mnster2024,
  author = {Münster, Alexandra and Huster, Julia and Sommer, Susanne and Traxler, Corinna and Votteler, Angeline and Hauber, Wolfgang},
  title = {Enhanced Risky Choice in Male Rats Elicited by the Acute Pharmacological Stressor Yohimbine Involves Prefrontal Dopamine D1 Receptor Activation},
  journal = {International Journal of Neuropsychopharmacology},
  year = {2024},
  doi = {10.1093/ijnp/pyae006}
}
Kostenlos starten →